On the nerve-injured side of triamcinolone-treated rats, there was a significant (71.5%) reduction in the number of TNFalpha-positive mast cells. Our results suggest that glucocorticoid therapy for neuropathic pain may work via the reduced expression of TNFalpha in endoneurial mast cells....
As advances in systemic therapy improve our ability to individualize breast cancer treatment, and improve response rates and outcomes, it is important to reevaluate the most appropriate form of local-regional management.
Ann H. Partridge, MD, MPH, discusses unique challenges associated with very young patients who have ER+/node-positive breast cancer.
Clinical relevance of the 21-gene Recurrence Score assay in treatment decisions for patients with node-positive breast cancer in the genomic eraIn contemporary management of early-stage breast cancer, clinical decisions regarding adjuvant systemic therapy are increasingly made after considering both genomic...
Axillary surgery in node-positive breast cancer. Breast. 2022;62(suppl 1):S50-S53. doi:10.1016/j.breast.2021.08.018PubMedGoogle ScholarCrossref 31. Kahler-Ribeiro-Fontana S, Pagan E, Magnoni F, et al. Long-term standard sentinel node biopsy after neoadjuvant ...
Adjuvant clodronate treatment does not reduce skeletal metastases and may reduce disease-free survival for node-positive breast cancer 来自 ResearchGate 喜欢 0 阅读量: 27 作者:B Ejlertsen,B Kristensen 摘要: dsRNA is a potent trigger of innate immune signaling, eliciting effects within virally ...
Dose-dense treatment prolongs disease-free survival of women with node positive breast cancer 来自 NCBI 喜欢 0 阅读量: 20 作者:C Dang,AD Seidman 摘要: Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, Newyork, NY, USA....
& Zee, B. Prognostic significance of the immunohistochemical reaction to human milk fat globule antibodies in node-negative and node-positive breast cancer. Breast Cancer Res Tr 21, 193–199 (1992). https://doi.org/10.1007/BF01975002 Download citation Issue DateOctober 1992 DOIhttps://doi.org...
We discuss why oncologists should not rely on the use of this biomarker for patients with early stage breast cancer and only 1–3 positive axillary nodes. First, Ki67 staining lacks analytical validity. Second, the performance of the biomarker for prognostic purposes is poor, with no compelling...
Objective:To explore the clinical effect and safety of docetaxel in treatment of breast cancer with resection of lymph node positive. Methods:60 cases of breast cancer after resection of axillary lymph node positive patients were chosen as research object from oncology department in our hospital betwe...